Skip to main navigation Skip to search Skip to main content

Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo

  • Eunju Leem
  • , Hyung Jun Kim
  • , Minji Choi
  • , Sehwan Kim
  • , Yong Seok Oh
  • , Kea Joo Lee
  • , Young Shik Choe
  • , Jae Young Um
  • , Won Ho Shin
  • , Jae Yeong Jeong
  • , Byung Kwan Jin
  • , Dong Woon Kim
  • , Catriona McLean
  • , Paul B. Fisher
  • , Nikolai Kholodilov
  • , Kwang Seok Ahn
  • , Jae Man Lee
  • , Un Ju Jung
  • , Seok Geun Lee
  • , Sang Ryong Kim

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The role of astrocyte elevated gene-1 (AEG-1) in nigral dopaminergic (DA) neurons has not been studied. Here we report that the expression of AEG-1 was significantly lower in DA neurons in the postmortem substantia nigra of patients with Parkinson's disease (PD) compared to age-matched controls. Similarly, decreased AEG-1 levels were found in the 6-hydroxydopamine (6-OHDA) mouse model of PD. An adeno-associated virus-induced increase in the expression of AEG-1 attenuated the 6-OHDA-triggered apoptotic death of nigral DA neurons. Moreover, the neuroprotection conferred by the AEG-1 upregulation significantly intensified the neurorestorative effects of the constitutively active ras homolog enriched in the brain [Rheb(S16H)]. Collectively, these results demonstrated that the sustained level of AEG-1 as an important anti-apoptotic factor in nigral DA neurons might potentiate the therapeutic effects of treatments, such as Rheb(S16H) administration, on the degeneration of the DA pathway that characterizes PD.

Original languageEnglish
Article number449
Number of pages15
JournalCell Death and Disease
Volume9
Issue number5
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this